Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.016x

Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.54 Million ≈ $3.88 Million USD) by net assets (CN¥1.69 Billion ≈ $246.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shaanxi Panlong Pharmaceutical Group Lim defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tokmanni Group Oyj HE:TOKMAN	-0.003x
Changchai Co Ltd SHE:000570	-0.037x
Anhui Liuguo Chemical Co Ltd SHG:600470	0.226x
Blue Label Telecoms Ltd JSE:BLU	0.456x
TCI Co Ltd TWO:8436	0.026x
Clean Energy Fuels Corp NASDAQ:CLNE	-0.015x
Solusi Bangun Indonesia Tbk PT JK:SMCB	0.046x
Eik fasteignafélag hf IC:EIK	0.017x

Annual Cash Flow Conversion Efficiency for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 002864 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.69 Billion ≈ $247.16 Million	CN¥63.01 Million ≈ $9.22 Million	0.037x	-61.00%
2024-12-31	CN¥1.64 Billion ≈ $239.57 Million	CN¥156.59 Million ≈ $22.91 Million	0.096x	+42.60%
2023-12-31	CN¥1.55 Billion ≈ $227.00 Million	CN¥104.05 Million ≈ $15.23 Million	0.067x	-49.30%
2022-12-31	CN¥947.60 Million ≈ $138.66 Million	CN¥125.36 Million ≈ $18.34 Million	0.132x	-7.97%
2021-12-31	CN¥807.21 Million ≈ $118.12 Million	CN¥116.04 Million ≈ $16.98 Million	0.144x	+14.65%
2020-12-31	CN¥735.66 Million ≈ $107.65 Million	CN¥92.24 Million ≈ $13.50 Million	0.125x	+24.61%
2019-12-31	CN¥674.71 Million ≈ $98.73 Million	CN¥67.89 Million ≈ $9.93 Million	0.101x	+31.36%
2018-12-31	CN¥611.60 Million ≈ $89.50 Million	CN¥46.85 Million ≈ $6.86 Million	0.077x	+49.58%
2017-12-31	CN¥555.58 Million ≈ $81.30 Million	CN¥28.45 Million ≈ $4.16 Million	0.051x	-72.92%
2016-12-31	CN¥327.82 Million ≈ $47.97 Million	CN¥61.99 Million ≈ $9.07 Million	0.189x	+34.49%
2015-12-31	CN¥288.89 Million ≈ $42.27 Million	CN¥40.62 Million ≈ $5.94 Million	0.141x	-28.71%
2014-12-31	CN¥246.19 Million ≈ $36.03 Million	CN¥48.56 Million ≈ $7.11 Million	0.197x	+63.50%
2013-12-31	CN¥210.84 Million ≈ $30.85 Million	CN¥25.43 Million ≈ $3.72 Million	0.121x	--

About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A

SHE:002864 China Drug Manufacturers - Specialty & Generic

Market Cap

$409.65 Million

CN¥2.80 Billion CNY

Market Cap Rank

#13415 Global

#4010 in China

Share Price

CN¥26.34

Change (1 day)

-1.75%

52-Week Range

CN¥26.34 - CN¥39.20

All Time High

CN¥74.44